Naloxone Hydrochloride Spray
Product Images NDC 51662-1659

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 51662-1659). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Directions (51662 1659 Directions)

Step-by-step instructional diagram for using NALOXONE HYDROCHLORIDE nasal spray in case of suspected overdose. It includes five steps with illustrations: 1) Check responsiveness, 2) Give the first nasal spray dose, 3) Call 911, 4) Watch and continue dosing every 2-3 minutes if needed, and 5) Stay with the person until ambulance arrives, giving additional doses if necessary.*

FDA Label Image

Unboxed (51662 1659 1 Unboxed)

This label for Naloxone Hydrochloride nasal spray includes a barcode and lines of numeric codes. It states "SEE MANUFACTURE'S INSERT" and notes the product is distributed by HF Acquisitions Co., LLC located in Mukilteo, WA 98275. The label is white with black text and a vertical 2D barcode on the right side.*

FDA Label Image

Rfid Label (51662 1659 2 Carton)

A white label displaying rows of numeric codes followed by a small QR code on the right. The label includes text instructing to see the manufacturer's insert and states distribution by HF Acquisitions Co., LLC, Mukilteo, WA 98275. No product name, strength, or dosage form is visible on this part of the label.*

FDA Label Image

Carton Label (51662 1659 2 Carton Photo)

NALOXONE HYDROCHLORIDE Nasal Spray 4 mg cartons show emergency treatment for opioid overdose with 2 single-dose nasal spray devices of 0.003 fl oz (0.1 mL) each. The packaging includes directions for use, warnings, inactive ingredients, and manufacturer information (Padagis). The label highlights original prescription strength, intended for nasal use only, and contains illustrations on usage steps and device parts.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.